Comment on CMS-2026-1255-0001

Summary: Blue Cross Blue Shield of Massachusetts (BCBSMA) provides mixed feedback on the proposed rule, supporting the incorporation of drugs into the Prior Authorization API but requesting a delayed compliance date. They also advocate for a one-year introductory period for public reporting of metrics and suggest pausing new API requirements until CMS can evaluate the usage data of existing APIs.